Laszlo Rosivall
Overview
Explore the profile of Laszlo Rosivall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Petho A, Tapolyai M, Szakacs-Pal T, Orosz P, Dezsi L, Rosivall L
Clin Nephrol
. 2020 Sep;
94(5):237-244.
PMID: 32870146
Introduction: The implantation of acute or chronic vascular accesses for hemodialysis (HD) in end-stage kidney disease patients is a critical skill procedure for nephrologists, with an impact on short- and...
12.
Momtazmanesh S, Ochs H, Uddin L, Perc M, Routes J, Vieira D, et al.
Am J Trop Med Hyg
. 2020 Apr;
102(6):1181-1183.
PMID: 32323644
Novel coronavirus disease (COVID-19), named a pandemic by the WHO, is the current global health crisis. National and international collaboration are indispensable for combating COVID-19 and other similar potential outbreaks....
13.
Kaly-Kullai K, Wittmann M, Noszticzius Z, Rosivall L
Physiol Int
. 2020 Mar;
107(1):1-11.
PMID: 32208977
Motivation: Viruses have caused many epidemics throughout human history. The novel coronavirus [10] is just the latest example. A new viral outbreak can be unpredictable, and development of specific defense...
14.
Kammer M, Heinzel A, Willency J, Duffin K, Mayer G, Simons K, et al.
Kidney Int
. 2019 Nov;
96(6):1381-1388.
PMID: 31679767
Clinical risk factors explain only a fraction of the variability of estimated glomerular filtration rate (eGFR) decline in people with type 2 diabetes. Cross-omics technologies by virtue of a wide...
15.
Dezsi L, Meszaros T, orfi E, Fulop T, Hennies M, Rosivall L, et al.
Molecules
. 2019 Sep;
24(18).
PMID: 31505853
Complement (C) activation can underlie the infusion reactions to liposomes and other nanoparticle-based medicines, a hypersensitivity syndrome that can be partially reproduced in animal models. However, the sensitivities and manifestations...
16.
Kozma G, Meszaros T, Vashegyi I, Fulop T, orfi E, Dezsi L, et al.
ACS Nano
. 2019 Jul;
13(8):9315-9324.
PMID: 31348638
Polyethylene glycol (PEG)-coated nanopharmaceuticals can cause mild to severe hypersensitivity reactions (HSRs), which can occasionally be life threatening or even lethal. The phenomenon represents an unsolved immune barrier to the...
17.
Fulop T, Kozma G, Vashegyi I, Meszaros T, Rosivall L, Urbanics R, et al.
J Control Release
. 2019 Jul;
309:333-338.
PMID: 31295544
Intravenous administration of liposomal drugs can entail infusion reactions, also known as hypersensitivity reactions (HSRs), that can be severe and sometimes life-threatening in a small portion of patients. One empirical...
18.
Petho A, P Szabo R, Tapolyai M, Rosivall L
Ren Fail
. 2019 Jun;
41(1):434-438.
PMID: 31162993
The successful implantation of peritoneal dialysis (PD) catheters is a critical skill procedure with the potential to impact both the short- and long-term success of renal replacement therapy and the...
19.
Tapolyai M, Faludi M, Berta K, Forro M, Zsom L, Petho A, et al.
Ren Fail
. 2019 Jun;
41(1):440-445.
PMID: 31162990
Diffuse enlargements of arteriovenous dialysis fistulas customarily attributed to either excessive arterial inflow or central outflow stenosis. The relationship between volume status and clinically enlarged (arteriovenous) fistula (CEF) formation in...
20.
Fintha A, Gasparics A, Rosivall L, Sebe A
Front Pharmacol
. 2019 May;
10:388.
PMID: 31057405
Back in 1995, a landmark paper was published, which shaped the fibrosis literature for many years to come. During the characterization of a fibroblast-specific marker (FSP1) in the kidneys, an...